购物车
全部删除
您的购物车当前为空
RGMB Protein, Human, Recombinant (hFc) is expressed in HEK293 Cells. The accession number is Q6NW40.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 μg | ¥ 493 | 6-8日内发货 | |
| 10 μg | ¥ 790 | 6-8日内发货 | |
| 20 μg | ¥ 1,330 | 5日内发货 | |
| 50 μg | ¥ 2,580 | 5日内发货 | |
| 100 μg | ¥ 5,170 | 5日内发货 | |
| 200 μg | ¥ 7,600 | 5日内发货 | |
| 500 μg | ¥ 15,300 | 5日内发货 | |
| 1 mg | ¥ 29,800 | 5日内发货 |
| 生物活性 | Immobilized BMP4 Protein, Human, Recombinant (E399D) (Cat#TMPY-06842) at 2 μg/mL (100 μL/well) can bind RGMB Protein, Human, Recombinant (hFc) (Cat#TMPY-07146) with a linear range of 0.16-4 ug/mL. |
| 产品描述 | RGMB Protein, Human, Recombinant (hFc) is expressed in HEK293 Cells. The accession number is Q6NW40. |
| 种属 | Human |
| 表达系统 | HEK293 Cells |
| 标签 | C-hFc |
| 蛋白编号 | Q6NW40 |
| 别名 | FLJ90406,DRAGON |
| 蛋白构建 | A DNA sequence encoding the Human RGMB (NP_001012779.2) (Met1-Asn413) was expressed with the Fc region of human IgG1 at the C-terminus. |
| 蛋白纯度 | ≥ 95% as determined by SDS-PAGE. ≥ 95% as determined by SEC-HPLC. |
| 分子量 | 67.26 kDa (predicted); 63.2 kDa and 20 kDa (reducing contition) |
| 内毒素 | < 1.0 EU per μg protein as determined by the LAL method. |
| 缓冲液 | Lyophilized from sterile PBS, pH 7.4. Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| 复溶方法 | Please refer to the lot-specific COA. |
| 存储 | It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
| 运输方式 | In general, Lyophilized powders are shipping with blue ice. |
| 研究背景 | RGMB was knocked down in breast cancer cells by way of an anti-RGMB ribozyme transgene. Knockdown of RGMB resulted in enhanced capacities of proliferation, adhesion, and migration in breast cancer cells. Further investigations demonstrated RGMB knockdown resulted in a reduced expression and activity of Caspase-3, accompanied with better survival in RGMB knockdown cells under serum starvation, which might be induced by its repression on MAPK JNK pathway. That RGMB may act as a negative regulator in breast cancer through BMP signaling. |